Epstein Secrets

f the presence or absence of malignant disease. ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay (Roche Diagnostics) PSA, FREE TNP Not Estab. ng/mL Test Not Performed: Specimen rejected for testing due to moderate or marked hemolysis. 0.70 101/27/2016 NOTE: Results cannot be interpre

U/L 29 01/27/2016 Phosphorus 3.8 2.7.4.5 mg/dL 3.4 01/27/2016 ALT 42 HI <41 U/L 29 01/27/2016 GGTP 19 C:4RDT0',./SClili,R TPT0c- , Cholestero 220 HI 10-71 U/L : <200 •L 18 „. 143 81/27/2016 ( 01/27/2016 Triglycerides 958 HI ROTE: The result for Triglycerides has been confirme

th different assay methods or kits cannot be interchangeably. ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay (Roche Diagnostics). Not Estab. ng/mL to moderate or marked of the obtained used I 0.33 ¶01/27/2016 % FREE PSA TNP FREE PSA RISK ASSESSMENT The probability of prostate

2.7.4.5 mg/dL 3.4 01/27/2016 ALT 42 HI <41 U/L 29 01/27/2016 GGTP 19 10-71 U/L 18 01/27/2016 i :,F li I (.,...ALILLILA:' • TPT 1)-1 Cholestero 219 HI <200 L 143 '... 01/27/2016 Triglycerides 950 HI NOTE: The result for Triglycerides has been confirmed <150 mg/dL by repeat analysi

th different assay methods or kits cannot be interchangeably. ASSAY INFORMATION: Method Electrocheedluninescence Immunoassay (Roche Diagnostics). Not Estab. ng/mi. to moderate or marked of the obtained used 1 0.33 101/27/2016 % FREE PSA TNP FREE PSA RISK ASSESSMENT The probability of prostate

0 U/L 29 01/27/2016 Phosphorus 3.8 2.7.4.5 mg/dL 3.4 01/27/2016 ALT 42 HI <41 U/L 29 81/27/2816 GGTP 19 10-71 U/L 18 01/27/2016 Cholestero 210 Al <200 •L 143 li- 01/27/2016 Triglycerides 950 HI NOTE: The result for Triglycerides has been confirmed <150 mg/dL by repeat analysis